-
1
-
-
84855999629
-
Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review
-
10.1186/1471-2407-12-30, 3293758, 22260541
-
Hartwig S, Syrjänen S, Dominiak-Felden G, Brotons M, Castellsague X. Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review. BMC Cancer 2012, 12:30. 10.1186/1471-2407-12-30, 3293758, 22260541.
-
(2012)
BMC Cancer
, vol.12
, pp. 30
-
-
Hartwig, S.1
Syrjänen, S.2
Dominiak-Felden, G.3
Brotons, M.4
Castellsague, X.5
-
2
-
-
61449242932
-
Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis
-
10.1002/ijc.24116, 19115209
-
De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009, 124:1626-36. 10.1002/ijc.24116, 19115209.
-
(2009)
Int J Cancer
, vol.124
, pp. 1626-1636
-
-
De Vuyst, H.1
Clifford, G.M.2
Nascimento, M.C.3
Madeleine, M.M.4
Franceschi, S.5
-
3
-
-
77954983213
-
Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)
-
10.1186/1758-3284-2-15, 2908081, 20587061
-
Dayyani F, Etzel CJ, Liu M, Ho CH, Lippman SM, Tsao AS. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol 2010, 2:15. 10.1186/1758-3284-2-15, 2908081, 20587061.
-
(2010)
Head Neck Oncol
, vol.2
, pp. 15
-
-
Dayyani, F.1
Etzel, C.J.2
Liu, M.3
Ho, C.H.4
Lippman, S.M.5
Tsao, A.S.6
-
4
-
-
70349678986
-
Human papillomavirus prevalence and type distribution in penile carcinoma
-
Miralles-Guri C, Bruni L, Cubilla AL, Castellsagué X, Bosch FX, de Sanjosé S. Human papillomavirus prevalence and type distribution in penile carcinoma. J ClinPathol 2009, 62:870-8.
-
(2009)
J ClinPathol
, vol.62
, pp. 870-878
-
-
Miralles-Guri, C.1
Bruni, L.2
Cubilla, A.L.3
Castellsagué, X.4
Bosch, F.X.5
de Sanjosé, S.6
-
5
-
-
79960308082
-
Economic burden of HPV-related cancers in France
-
10.1016/j.vaccine.2011.05.018, 21616117
-
Borget I, Abramowitz L, Mathevet P. Economic burden of HPV-related cancers in France. Vaccine 2011, 29:5245-9. 10.1016/j.vaccine.2011.05.018, 21616117.
-
(2011)
Vaccine
, vol.29
, pp. 5245-5249
-
-
Borget, I.1
Abramowitz, L.2
Mathevet, P.3
-
6
-
-
59649093121
-
An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England
-
10.1038/sj.bjc.6604871, 2658550, 19156144
-
Robinson D, Coupland V, Møller H. An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England. Br J Cancer 2009, 100:527-31. 10.1038/sj.bjc.6604871, 2658550, 19156144.
-
(2009)
Br J Cancer
, vol.100
, pp. 527-531
-
-
Robinson, D.1
Coupland, V.2
Møller, H.3
-
7
-
-
77951572361
-
Oropharyngeal carcinoma related to human papillomavirus
-
10.1136/bmj.c1439, 20339160
-
Mehanna H, Jones TM, Gregoire V, Ang KK. Oropharyngeal carcinoma related to human papillomavirus. BMJ 2010, 340:c1439. 10.1136/bmj.c1439, 20339160.
-
(2010)
BMJ
, vol.340
-
-
Mehanna, H.1
Jones, T.M.2
Gregoire, V.3
Ang, K.K.4
-
8
-
-
67449090374
-
Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?
-
10.1002/ijc.24339, 19330833
-
Nasman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, Ahrlund-Richter S, Marklund L, Romanitan M, Lindquist D, Ramqvist T, Lindholm J, Sparén P, Ye W, Dahlstrand H, Munck-Wikland E, Dalianis T. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?. Int J Cancer 2009, 125:362-366. 10.1002/ijc.24339, 19330833.
-
(2009)
Int J Cancer
, vol.125
, pp. 362-366
-
-
Nasman, A.1
Attner, P.2
Hammarstedt, L.3
Du, J.4
Eriksson, M.5
Giraud, G.6
Ahrlund-Richter, S.7
Marklund, L.8
Romanitan, M.9
Lindquist, D.10
Ramqvist, T.11
Lindholm, J.12
Sparén, P.13
Ye, W.14
Dahlstrand, H.15
Munck-Wikland, E.16
Dalianis, T.17
-
9
-
-
34250843134
-
Potential impact of human papillomavirus vaccines on public STD clinic workloads and on opportunities to diagnose and treat other sexually transmitted diseases
-
Dempsey AF, Koutsky LA, Golden M. Potential impact of human papillomavirus vaccines on public STD clinic workloads and on opportunities to diagnose and treat other sexually transmitted diseases. Sex Transm Dis 2007, 34:503-7.
-
(2007)
Sex Transm Dis
, vol.34
, pp. 503-507
-
-
Dempsey, A.F.1
Koutsky, L.A.2
Golden, M.3
-
10
-
-
78650255358
-
Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data
-
10.1016/S1473-3099(10)70225-5, 21067976
-
Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, Wand H, Fairley CK. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 2011, 11:39-44. 10.1016/S1473-3099(10)70225-5, 21067976.
-
(2011)
Lancet Infect Dis
, vol.11
, pp. 39-44
-
-
Donovan, B.1
Franklin, N.2
Guy, R.3
Grulich, A.E.4
Regan, D.G.5
Ali, H.6
Wand, H.7
Fairley, C.K.8
-
11
-
-
33747892746
-
Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease
-
Lacey CJ, Lowndes CM, Shah KV. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006, 24(Suppl 3):35-41.
-
(2006)
Vaccine
, vol.24
, Issue.SUPPL. 3
, pp. 35-41
-
-
Lacey, C.J.1
Lowndes, C.M.2
Shah, K.V.3
-
12
-
-
70349314677
-
Assessing incidence and economic burden of genital warts with data from a US commercially insured population
-
10.1185/03007990903136378, 19650749
-
Hoy T, Singhal PK, Willey VJ, Insinga RP. Assessing incidence and economic burden of genital warts with data from a US commercially insured population. Curr Med Res Opin. 2009, 25:2343-51. 10.1185/03007990903136378, 19650749.
-
(2009)
Curr Med Res Opin.
, vol.25
, pp. 2343-2351
-
-
Hoy, T.1
Singhal, P.K.2
Willey, V.J.3
Insinga, R.P.4
-
13
-
-
33847199744
-
Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France
-
10.1016/j.gyobfe.2006.12.010, 17270482
-
Monsonégo J, Breugelmans JG, Bouée S, Lafuma A, Bénard S, Rémy V. Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France. Gynecol Obstet Fertil 2007, 35:107-13. 10.1016/j.gyobfe.2006.12.010, 17270482.
-
(2007)
Gynecol Obstet Fertil
, vol.35
, pp. 107-113
-
-
Monsonégo, J.1
Breugelmans, J.G.2
Bouée, S.3
Lafuma, A.4
Bénard, S.5
Rémy, V.6
-
14
-
-
83455257868
-
Economic and humanistic burden of external genital warts
-
10.2165/11591170-000000000-00000, 22201520
-
Raymakers AJ, Sadatsafavi M, Marra F, Marra CA. Economic and humanistic burden of external genital warts. PharmacoEconomics 2012, 30:1-16. 10.2165/11591170-000000000-00000, 22201520.
-
(2012)
PharmacoEconomics
, vol.30
, pp. 1-16
-
-
Raymakers, A.J.1
Sadatsafavi, M.2
Marra, F.3
Marra, C.A.4
-
15
-
-
59449097418
-
Epidemiology and cost of treatment of genital warts in Spain
-
Castellsagué X, Cohet C, Puig-Tintoré LM, Acebes LO, Salinas J, San Martin M, Breitscheidel L, Rémy V. Epidemiology and cost of treatment of genital warts in Spain. Eur J Public Health 2009, 19(1):106-10.
-
(2009)
Eur J Public Health
, vol.19
, Issue.1
, pp. 106-110
-
-
Castellsagué, X.1
Cohet, C.2
Puig-Tintoré, L.M.3
Acebes, L.O.4
Salinas, J.5
San Martin, M.6
Breitscheidel, L.7
Rémy, V.8
-
16
-
-
79551558109
-
Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males
-
10.1056/NEJMoa0909537, 3495065, 21288094
-
Giuliano AR, Palefsky JM, Goldstone S, Moreira ED, Penny ME, Aranda C, Vardas E, Moi H, Jessen H, Hillman R, Chang YH, Ferris D, Rouleau D, Bryan J, Marshall JB, Vuocolo S, Barr E, Radley D, Haupt RM, Guris D. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. New Engl J Med 2011, 364:401-11. 10.1056/NEJMoa0909537, 3495065, 21288094.
-
(2011)
New Engl J Med
, vol.364
, pp. 401-411
-
-
Giuliano, A.R.1
Palefsky, J.M.2
Goldstone, S.3
Moreira, E.D.4
Penny, M.E.5
Aranda, C.6
Vardas, E.7
Moi, H.8
Jessen, H.9
Hillman, R.10
Chang, Y.H.11
Ferris, D.12
Rouleau, D.13
Bryan, J.14
Marshall, J.B.15
Vuocolo, S.16
Barr, E.17
Radley, D.18
Haupt, R.M.19
Guris, D.20
more..
-
17
-
-
77956874341
-
Impact of vaccinating boys and men against HPV in the United States
-
10.1016/j.vaccine.2010.08.030, 20713101
-
Elbasha EH, Dasbach EJ. Impact of vaccinating boys and men against HPV in the United States. Vaccine 2010, 28:6858-67. 10.1016/j.vaccine.2010.08.030, 20713101.
-
(2010)
Vaccine
, vol.28
, pp. 6858-6867
-
-
Elbasha, E.H.1
Dasbach, E.J.2
-
18
-
-
82455175222
-
The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia
-
10.1016/j.vaccine.2011.02.091, 21419773
-
Smith MA, Lew JB, Walker RJ, Brotherton JM, Nickson C, Canfell K. The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia. Vaccine 2011, 29:9112-22. 10.1016/j.vaccine.2011.02.091, 21419773.
-
(2011)
Vaccine
, vol.29
, pp. 9112-9122
-
-
Smith, M.A.1
Lew, J.B.2
Walker, R.J.3
Brotherton, J.M.4
Nickson, C.5
Canfell, K.6
-
19
-
-
79960149018
-
Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity
-
10.1093/infdis/jir285, 21742835
-
Brisson M, van de Velde N, Franco EL, Drolet M, Boily MC. Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity. J Infect Dis 2011, 204:372-6. 10.1093/infdis/jir285, 21742835.
-
(2011)
J Infect Dis
, vol.204
, pp. 372-376
-
-
Brisson, M.1
van de Velde, N.2
Franco, E.L.3
Drolet, M.4
Boily, M.C.5
-
20
-
-
80755152170
-
An overview on the implementation of HPV vaccination in Europe
-
Bonanni P, Levi M, Latham NB, Bechini A, Tiscione E, Lai P, Panatto D, Gasparini R, Boccalini S. An overview on the implementation of HPV vaccination in Europe. Hum Vaccin 2011, 7(Suppl):128-35.
-
(2011)
Hum Vaccin
, vol.7
, Issue.SUPPL.
, pp. 128-135
-
-
Bonanni, P.1
Levi, M.2
Latham, N.B.3
Bechini, A.4
Tiscione, E.5
Lai, P.6
Panatto, D.7
Gasparini, R.8
Boccalini, S.9
-
21
-
-
84855163224
-
Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models
-
10.1371/journal.pmed.1001147, 3243713, 22205887
-
Bogaards JA, Kretzschmar M, Xiridou M, Meijer CJ, Berkhof J, Wallinga J. Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models. PLoS Med 2011, 8(12):e1001147. 10.1371/journal.pmed.1001147, 3243713, 22205887.
-
(2011)
PLoS Med
, vol.8
, Issue.12
-
-
Bogaards, J.A.1
Kretzschmar, M.2
Xiridou, M.3
Meijer, C.J.4
Berkhof, J.5
Wallinga, J.6
-
22
-
-
33846102585
-
Model for assessing human papillomavirus vaccination strategies
-
10.3201/eid1301.060438, 2725801, 17370513
-
Elbasha EH, Dasbach EJ, Insinga RP. Model for assessing human papillomavirus vaccination strategies. Emerg Infect Dis 2007, 13:28-41. 10.3201/eid1301.060438, 2725801, 17370513.
-
(2007)
Emerg Infect Dis
, vol.13
, pp. 28-41
-
-
Elbasha, E.H.1
Dasbach, E.J.2
Insinga, R.P.3
-
23
-
-
45249112545
-
The epidemiological and economic impact of a quadrivalent human papillomavirus vaccine (6/11/16/18) in the UK
-
10.1111/j.1471-0528.2008.01743.x, 18503574
-
Dasbach EJ, Insinga RP, Elbasha EH. The epidemiological and economic impact of a quadrivalent human papillomavirus vaccine (6/11/16/18) in the UK. BJOG 2008, 115:947-56. 10.1111/j.1471-0528.2008.01743.x, 18503574.
-
(2008)
BJOG
, vol.115
, pp. 947-956
-
-
Dasbach, E.J.1
Insinga, R.P.2
Elbasha, E.H.3
-
24
-
-
80054831192
-
Comparing bivalent and quadrivalent humanpapillomavirus vaccines: economic evaluation based on transmission model
-
10.1136/bmj.d5775, 3181234, 21951758
-
Jit M, Chapman R, Hughes O, Choi YH. Comparing bivalent and quadrivalent humanpapillomavirus vaccines: economic evaluation based on transmission model. BMJ 2011, 343:d5775. 10.1136/bmj.d5775, 3181234, 21951758.
-
(2011)
BMJ
, vol.343
-
-
Jit, M.1
Chapman, R.2
Hughes, O.3
Choi, Y.H.4
-
25
-
-
70349167019
-
Description of the national situation of cervical cancer screening in the member states of the European Union
-
10.1016/j.ejca.2009.07.017, 19744852, Working Group on the Registration and Monitoring of Cervical Cancer Screening Programmes in the European Union; within the European Network for Information on Cancer (EUNICE)
-
Anttila A, Ronco G, Working Group on the Registration and Monitoring of Cervical Cancer Screening Programmes in the European Union; within the European Network for Information on Cancer (EUNICE) Description of the national situation of cervical cancer screening in the member states of the European Union. Eur J Cancer 2009, 45:2685-708. 10.1016/j.ejca.2009.07.017, 19744852, Working Group on the Registration and Monitoring of Cervical Cancer Screening Programmes in the European Union; within the European Network for Information on Cancer (EUNICE).
-
(2009)
Eur J Cancer
, vol.45
, pp. 2685-2708
-
-
Anttila, A.1
Ronco, G.2
-
26
-
-
80053987404
-
The cost-effectiveness of male HPV vaccination in the United States
-
10.1016/j.vaccine.2011.07.096, 21816193
-
Chesson HW, Ekwueme DU, Saraiya M, Dunne EF, Markowitz LE. The cost-effectiveness of male HPV vaccination in the United States. Vaccine 2011, 29:8443-50. 10.1016/j.vaccine.2011.07.096, 21816193.
-
(2011)
Vaccine
, vol.29
, pp. 8443-8450
-
-
Chesson, H.W.1
Ekwueme, D.U.2
Saraiya, M.3
Dunne, E.F.4
Markowitz, L.E.5
|